title: Unfinished business: ongoing ethical exceptionalism in the oversight of human pluripotent stem cell research in Canada.
abstract: In this article, we critically examine the arguments for and against the exceptional status given human pluripotent stem cell research in Canada (through the latest [December 2010] revision of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans), and conclude that this exceptionalism is unwarranted and ethically unsound. In our view, the three federal research granting agencies should honor their longstanding commitment that researchers, research sponsors, and Research Ethics Boards in Canada have access to "a single reference document for all research involving humans conducted under the auspices of institutions eligible for Agency funding." As well, responsibility for the development, interpretation, and implementation of Canada's research ethics guidelines should be under the authority of a single oversight body that is independent of the federal research granting Agencies.
authors.affiliation: Novel Tech Ethics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. francoise.baylis@dal.ca
authors.forename: Françoise
authors.initials: F
authors.lastname: Baylis
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Downie
mesh_terms: D002170:Canada; D016265:Conflict of Interest; D032984:Ethics, Research; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D039904:Pluripotent Stem Cells / Q000637:transplantation*; D017410:Practice Guidelines as Topic / Q000592:standards*; D057905:Stem Cell Research / Q000941:ethics*